Asb Consultores, LLC Pfizer Inc Transaction History

Asb Consultores, LLC

$276 Million
Q2 2024

A detailed history of Asb Consultores, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Asb Consultores, LLC holds 15,558 shares of PFE stock, worth $461,450. This represents 0.16% of its overall portfolio holdings.

Number of Shares

15,558

Previous 18,919 17.77%

Holding current value

$461,450

Previous $525,000 17.14%

% of portfolio

0.16%

Previous 0.14%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$25.26 - $29.6 $84,898 - $99,485	-3,361 Reduced 17.77%	15,558 $435,000
Q1 2024 May 14, 2024	BUY	$25.89 - $29.73 $301,851 - $346,622	11,659 Added 160.59%	18,919 $525,000
Q4 2023 Feb 13, 2024	SELL	$26.13 - $33.94 $185,209 - $240,566	-7,088 Reduced 49.4%	7,260 $209,000
Q3 2023 Nov 28, 2023	SELL	$32.09 - $37.51 $133,526 - $156,079	-4,161 Reduced 22.48%	14,348 $475,000
Q2 2023 Aug 07, 2023	BUY	$36.12 - $41.79 $45,980 - $53,198	1,273 Added 7.39%	18,509 $678,000
Q1 2023 May 03, 2023	BUY	$39.39 - $51.28 $219,284 - $285,475	5,567 Added 47.71%	17,236 $703,000
Q4 2022 Feb 13, 2023	SELL	$41.75 - $54.5 $38,368 - $50,085	-919 Reduced 7.3%	11,669 $598,000
Q3 2022 Jan 11, 2023	BUY	$43.76 - $53.42 $66,121 - $80,717	1,511 Added 13.64%	12,588 $551,000
Q2 2022 Jan 11, 2023	BUY	$46.53 - $55.17 $28,848 - $34,205	620 Added 5.93%	11,077 $581,000
Q1 2022 Jan 11, 2023	BUY	$45.75 - $56.69 $478,407 - $592,807	10,457 New	10,457 $541,000
Q4 2021 Jan 11, 2023	SELL	$41.32 - $61.25 $92,928 - $137,751	-2,249 Reduced 17.87%	10,339 $611,000

Others Institutions Holding PFE

# of Institutions

3,218

Shares Held

3.71B

Call Options Held

73.2M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $166B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Asb Consultores, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Asb Consultores, LLC with notifications on news.

Account

Asb Consultores, LLC Pfizer Inc Transaction History